Today, Mohsin Bashir and John Hood commented about whether VGK-N, XEI-T, VTI-N, XID-T, XTR-T, VIX-I, HNU-T, CBO-T, XEG-T, VV-N, CASH, ZWH-T, ZUT-T, XFN-T, ZWA-T, XSP-T, SCHB-N, MATW-Q, MDT-N, CNQ-T, UFS-T, MFC-T, G-T, BA-N, KEY-T, BAC-N, GE-N, CGX-T, TMO-N, IFF-N, CPG-T, TRP-T, SU-T, META-Q, POT-T, CP-T, GSK-N are stocks to buy or sell.
One of those companies that can benefit from a rising interest rate environment. The only thing that has kept him away from this company has been the comparison of its valuation multiple relative to the multiple of the banks. The banks actually work out cheaper. While interest rates are still low, there is more leverage to generate more cash flows from a bank than a company like this.
Spinning off tons of cash. One of the largest senior producers in Western Canada, and produce about a million barrels of oil a day. Phase 2 expansion in Horizon as well as its thermal projects, gives it a really good line of sight for amping up its production with another 250 million barrels by 2017. This will mean an extra $2 billion per year of free cash flow available, which could be used for increasing dividends or further asset purchases. Also, have a nice handful of royalty assets that could be spun out. Yield of 1.89%.
On the cusp of a transformational acquisition, the $43 billion purchase of Covidian (COV-N). This changes their headquarters with a tax inversion deal, making Covidian a 30% owner of the new Medtronic. In order for a tax inversion to take place, you have to own at least 20%, so maybe the extra buffer of 30% will appease regulators, and keep everybody happy. This would allow them to have foreign profit, somewhere in the realm of about $14 billion, and be able to re-disperse them among their existing shareholders. A good line of sight for a growing dividend, further share buybacks, as well as future tuck in acquisitions. This deal would make them the biggest and most diversified medical devices company globally. Also, developing a series of new products. Yield of 1.97%.
One of the most important key suppliers to the death care industry, in supplying caskets and cremation equipment to funeral homes. Own 70% market share in bronze and granite memorials. In the US there are a higher number of people that are opting for cremation, about 36%, which is forecasted to grow to about 56% in 10 years. Yield of 1.03%.
Markets. It is difficult to see where anything is going to come out and really hit the markets. There could be an adjustment of 10%-20%, but it is going to be short. The markets are going to come back. You could have volatility, but there is nothing out there that is going to push us into something like we had in 2007-2008. Generally earnings have been great and he thinks that is going to continue. Feels the US recovery is real and is going to continue to carry on.
In a TFSA account, is it better to buy ETFs or individual stocks? Which stocks or sectors would be a smart bet for a long-term hold? He would recommend an ETF, because how many stocks can you buy in a normal sized TFSA account? ETFs gives you diversification, and avoids the risk of an individual stock. Consider XIU for the Canadian and XSP as well as some of the competitor products from Vanguard. As long as they are good, broad-based ETF’s, you’ll be fine.
This would have been a buy earlier in the year in the lower $20’s. Now it looks like it has woken up from the dead. A little bit rich here, but is probably one of his favourites. Good set of assets and good management team. You probably should wait for the stock price to cool off.